AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

4,447.00p
   
  • Change Today:
    -34.00p
  • 52 Week High: 5,508.00
  • 52 Week Low: 4,007.00
  • Currency: UK Pounds
  • Shares Issued: 1,265.79m
  • Volume: 1,614,494
  • Market Cap: 56,290m
  • RiskGrade: 211

AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

1 Day Chart (18-08-2017)

6 Month Chart

AstraZeneca Financials

Latest F'cast
Div Yield 4.9% 4.1%
Div Cover 1.5 1.4
Op Mrgn 23.0% 25.8%
ROCE n/a  
Latest F'cast
P/E 13.3 15.5
PEG 11.3 n/a
Pr/Revenue 3.4 3.4
Pr/Book 4.3  
Latest F'cast
Revenue -9.8% -39.6%
PBT 15.7% -6.5%
EPS 1.2% -13.2%
DPS n/a -41.2%

AstraZeneca Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 27,973.00 7,646.00 683.00¢ 5.5 n/a -6% 280.00¢ 7.5%
31-Dec-13 25,711.00 3,267.00 505.00¢ 9.1 n/a -26% 280.00¢ 6.1%
31-Dec-14 26,095.00 1,246.00 428.00¢ 13.7 n/a -15% 280.00¢ 4.8%
31-Dec-15 23,641.00 3,069.00 426.00¢ 14.0 n/a -0% 280.00¢ 4.7%
31-Dec-16 21,319.00 3,552.00 431.00¢ 13.3 13.3 +1% 280.00¢ 4.9%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AstraZeneca Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 16,581.69 4,273.33 287.58p 15.5 n/a -13% 212.10p 4.1%
31-Dec-18 17,190.38 4,442.59 303.59p 14.6 2.6 +6% 213.97p 4.2%

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.

AstraZeneca Company Announcements

Lynparza gets broad FDA approval in ovarian cancer 18-Aug-2017 07:00 RNS
Directorate Change 16-Aug-2017 07:00 RNS
Holding(s) in Company 14-Aug-2017 16:30 RNS

Latest AstraZeneca Director Deals

Traded Action Notifier PriceAmountValue
27-Jul-17 Buy Philip A J Broadley 4,282.00p 2,300 98,486.00
27-Jul-17 Buy Nazneen Rahman 4,370.13p 39 1,704.35
27-Jul-17 Buy Nazneen Rahman 4,335.48p 461 19,986.58

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 4,447.00p
Change Today -34.00p
% Change -0.76 %
52 Week High 5,508.00
52 Week Low 4,007.00
Volume 1,614,494
Shares Issued 1,265.79m
Market Cap 56,290m
RiskGrade 211

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
5.9% below the market average5.9% below the market average5.9% below the market average5.9% below the market average5.9% below the market average
96.55% above the sector average96.55% above the sector average96.55% above the sector average96.55% above the sector average96.55% above the sector average
Price Trend
40.16% below the market average40.16% below the market average40.16% below the market average40.16% below the market average40.16% below the market average
3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average
Income
79.24% above the market average79.24% above the market average79.24% above the market average79.24% above the market average79.24% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average
Growth
53.15% below the market average53.15% below the market average53.15% below the market average53.15% below the market average53.15% below the market average
77.27% below the sector average77.27% below the sector average77.27% below the sector average77.27% below the sector average77.27% below the sector average

What The Brokers Say

Strong Buy 18
Buy 2
Neutral 14
Sell 1
Strong Sell 4
Total 39
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  Interim 2nd Interim
Ex-Div 10-Aug-17 16-Feb-17
Paid 11-Sep-17 20-Mar-17
Amount 90.00¢ 190.00¢

Trades for 18-Aug-2017

Time Volume / Share Price
17:09 140 @ 4,428.35p
17:03 15,898 @ 4,446.72p
17:03 1,048 @ 4,426.55p
17:02 4,350 @ 4,432.55p
17:01 3,292 @ 4,431.30p

Top of Page